BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11344580)

  • 1. Augmentation of prolactin secretion by estrogen in hypogonadal women.
    Yen SS; Ehara Y; Siler TM
    J Clin Invest; 1974 Feb; 53(2):652-5. PubMed ID: 11344580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
    Lachelin GC; Yen SS
    J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback modulation of hypothalamic-pituitary unit by estrogen in the secretion of gonadotropins and prolactin in humans.
    Yen SS; Siler TM; VandenBerg G; Ehara Y
    Adv Biosci; 1975; 15():163-80. PubMed ID: 809301
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of estrogen priming of hypogonadal women on the release of gonadotropins and prolactin in response to 2-hydroxyestradiol.
    Adashi EY; Fishman J; Yen SS
    Life Sci; 1982 Nov; 31(18):1903-9. PubMed ID: 6817001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acutely administered 2-hydroxyestrone on the release of gonadotropins and prolactin before and after estrogen priming in hypogonadal women.
    Adashi EY; Rakoff J; Divers W; Fishman J; Yen SS
    Life Sci; 1979 Dec 10-17; 25(24-25):2051-5. PubMed ID: 537468
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
    Helgason S
    Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen modulates the action of nitric oxide in the medial preoptic area on luteinizing hormone and prolactin secretion.
    Moreno AS; Franci CR
    Life Sci; 2004 Mar; 74(16):2049-59. PubMed ID: 14967199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the feedback actions of estrogen on gonadotropin and prolactin release in infantile female rats.
    Andrews WW; Ojeda SR
    Endocrinology; 1977 Nov; 101(5):1517-23. PubMed ID: 913323
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of several estrogens on serum gonadotropin levels in postmenopausal women.
    Franchimont P; Legros JJ; Meurice J
    Horm Metab Res; 1972 Jul; 4(4):288-92. PubMed ID: 5086200
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin antagonist-induced lowering of prolactin secretion does not affect the pattern of pulsatile secretion of follicle-stimulating hormone and luteinizing hormone in the bitch.
    Beijerink NJ; Kooistra HS; Dieleman SJ; Okkens AC
    Reproduction; 2004 Aug; 128(2):181-8. PubMed ID: 15280557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropins and prolactin during estrogen replacement therapy.
    Helgason S; Carlström K; Damber MG; von Schoultz B
    Acta Obstet Gynecol Scand; 1981; 60(5):515-6. PubMed ID: 6795895
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogenic activities of estradiol enantate and ethinylestradiol compared at a clinical level.
    Moguilevsky JA; Wiemeyer JC; Sagasta CL; Leiderman S
    Arzneimittelforschung; 1986 Nov; 36(11):1671-4. PubMed ID: 3101711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals.
    Mueller A; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Dittrich R
    Horm Metab Res; 2006 Mar; 38(3):183-7. PubMed ID: 16673210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amenorrhea and the pill].
    Verdino P; Viard R; Harter M
    Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone.
    Schinfeld JS; Tulchinsky D; Schiff I; Fishman J
    J Clin Endocrinol Metab; 1980 Feb; 50(2):408-10. PubMed ID: 7354124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogens on luteinizing hormone release in testicular feminization syndrome before and after gonadectomy.
    Corsello SM; De Rosa G; Liberale I; Menini E; Moneta E; Pasargiklian E
    Obstet Gynecol; 1984 Mar; 63(3):312-7. PubMed ID: 6230548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen on the release of gonadotropins and prolactin in male pseudohermaphrodites.
    Barbarino A; De Marinis L; Lafuenti G; Muscatello P; Matteucci B
    J Endocrinol Invest; 1979; 2(1):41-4. PubMed ID: 489915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
    Nishi T; Nakano R; Yagi S
    Horm Res; 1989; 32(5-6):193-7. PubMed ID: 2517493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.